Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker
about
Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityPatient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicityTCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma.Identification of GRB2 and GAB1 coexpression as an unfavorable prognostic factor for hepatocellular carcinoma by a combination of expression profile and network analysis.Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinomaDiffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus.Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analysesDNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma.Familial hepatocellular carcinoma in an endemic area: two case reports.Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer StagesGene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmiumGene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis.Biomarker development, from bench to bedside.Disease monitoring of hepatocellular carcinoma through metabolomics.Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics.Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma.Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer.Whole Transcriptome Profiling: An RNA-Seq Primer and Implications for Pharmacogenomics Research.Epigenetic alterations in TRAMP mice: epigenome DNA methylation profiling using MeDIP-seq.Familial hepatocellular carcinoma: 'A model for studying preventive and therapeutic measures'Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
P2860
Q27027301-CA2459B6-6C56-49F1-9CEB-832A54018B26Q29247916-E75D0AAE-B00B-48B0-801A-F4E18FEF5A73Q30987443-05C00483-404A-4294-8A1C-13912EC7906FQ31147209-0F744CCE-B3A0-4428-95F1-B106CACA53A4Q34217385-0FCE7471-4A39-4F6F-80D2-FF2CE3EDD8BCQ34611722-4F7A2BE3-4F9D-410F-9392-49597D144298Q34769837-7A790B56-D1DE-4458-9A81-64DBCD81058EQ35568894-CF7BCE60-92A0-4FDA-AF13-E99CB1F327CBQ35765290-3DA87009-82A3-44FB-9D02-4D179BDD92CBQ36084511-86556B73-CE6E-4F56-9D16-4B9D2F4B3C4EQ36161911-789E8556-BD52-4BE6-A981-706298E46EB0Q37580206-2A6395F4-335E-4042-AE55-A0BDB8EB07CAQ38479037-48FD4D1A-751E-45FD-8FA6-395958794897Q38569348-BABBEF65-0F94-430C-92D0-30498C0B9FFFQ38768256-71CE362F-053E-4102-90BE-EC502EADA533Q41322632-EBDB4A4F-A9D6-4CED-88C7-95FAD7CBFA1BQ41924403-2784FFA9-E30D-4D89-BAE7-8E724FD08018Q43544108-7C0FE2F8-0058-482D-89A9-A12617DE4A9AQ48094189-D9D0854C-4090-47F1-803B-CEA95595307BQ49231491-355CD9AE-98B5-4AA8-B668-9C1673019512Q49841634-44A7FB66-5ACA-4CC4-8D71-38BBE4E60D81Q49985254-842FCDD7-8BA0-4FE1-99BD-7FC85DAD143FQ57299782-78844C6D-7B2D-49A6-9282-2BB047CACC2CQ58062853-989D4137-D78B-4418-92D4-4403665AC9E9
P2860
Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Global gene expression profili ...... epatocellular carcinoma marker
@ast
Global gene expression profili ...... epatocellular carcinoma marker
@en
type
label
Global gene expression profili ...... epatocellular carcinoma marker
@ast
Global gene expression profili ...... epatocellular carcinoma marker
@en
prefLabel
Global gene expression profili ...... epatocellular carcinoma marker
@ast
Global gene expression profili ...... epatocellular carcinoma marker
@en
P2093
P2860
P50
P1433
P1476
Global gene expression profili ...... epatocellular carcinoma marker
@en
P2093
Aileen Marshall
Graeme Alexander
Susan Davies
P2860
P304
P356
10.1371/JOURNAL.PONE.0059459
P407
P577
2013-03-18T00:00:00Z